Objectives: Estimates of the lifetime prevalence of external genital warts (EGW) and genital herpes in the European Union (EU) range from 0.47% to 1.52% and 0.59% to 1.43% respectively. What has not been assessed is the impact of the experience on current health related quality of life at the general population level. The purpose of this analysis is to remedy this deficiency.
Methods
■ The study is based on data from the Internet-based 2008 National Health and Wellness Survey undertaken in the UK, France, Spain, Germany and Italy. This study population, 53,524 respondents, identified 584 individuals with EGW, and 583 with GH (including 63 with experience of both infections).
■ HRQoL utility scores were estimated for the SF-6D instrument (score 0 -100). The quantitative evaluation involved specifying a linear (OLS) regression model to include categorical variables for (i) experience of EGW, GH and both; (ii) age; (iii) gender; (iv) household income; (v) education; (vi) health risk factors -BMI, alcohol use and smoking; and (vi) Charlson comorbidity index.
Introduction
■ External genital warts (EGWs) and genital herpes (GH) are commonly experienced sexually transmitted infections. In the European Union estimates of the lifetime prevalence range from 0.45% to 1.52% in the case of EGW and 0.59% to 1.43% in the case of GH. Assessment of the impact of these infections on HRQoL have focused on GH, to include the development of generic instruments (Meads et al, 2010 ) and the comparison of measures (Fisman, 2004) . Studies have focused on assessments within clinical trial environments. There are no pan-national studies and none that have attempted, using a generic HRQoL instrument, to assess the relative burden of these two infections.
Objectives
■ The aims here are: (i) to provide estimates of the population experience of EGW and GH; and (ii) to assess the burden of these two infections in terms of their impact on HRQoL utilities for 5 European countries.
Results
■ Overall, the estimated population prevalence of persons experiencing EGW (to include GH) was similar to that for persons experiencing GH (to include EGW) at 1.09%.
■ Among those only experiencing EGW the population prevalence ranged from 0.47 to 1.52; for GH the range was 0.59 to 1.45.
■ In the case of EGW, the highest prevalence was for the UK; in the case of GH the highest prevalence was for France.
■ Modeled results for the impact of EGW and GH on HRQoL indicated that both had a negative impact on utility scores. The impact of GH (-3.519; t=-4.35) was somewhat greater than for EGW (-2.471; t = -6.21) ( Table 1) .
Discussion
■ Experience of EGW and GH has a negative impact of HRQoL; although experience of both has a positive effect (which may be due to small sample size).
■ Compared to the reference population, the impact on HRQoL is not out of line with the impact of health risk factors (except the experience of morbid obesity).
■ The impact of GH, perhaps not surprisingly given its chronic nature and the attention given to it in the STI literature, is greater than that for EGW.
■ It is also of interest to note that while France reports the highest prevalence of GH the UK reports the highest prevalence of GH. This may reflect the weight that is given to specific STI programs in the two countries.
Conclusions
■ This is the first time, at a pan-national level that the relative contribution of EGW and GH to HRQoL has been evaluated. While both STIs have a significant, negative impact, there is clearly scope for a more intensive analysis to assess their independent contribution to HRQoL, particularly at the country level. 
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Results (continued)
■ Surprisingly, the impact of both EGW and GH was positive. The negative impact of EGW and GH was similar to the impact of comorbidities (CCI -2.528) and the being underweight or overweight (but dwarfed by morbid obesity). Among the other independent variables (i) males report a greater HRQoL than females; (ii) higher educational attainment is associated with a greater HRQoL; and (iii) income has a positive impact on HRQoL.
